Skip to main
We’re doing some system maintenance
  1. Home
  2. Stocks
  3. Organovo Hlds
ONVO

Buy Organovo Hlds (ONVO) Stock

ONVO
See ONVO stock price and Buy/Sell Organovo Hlds with any amount of money. Discuss news and analyst's price prediction with the investor community. Enter your cell phone number to get started.
ONVO

Organovo Hlds (ONVO)

About Organovo Hlds (ONVO)

Organovo Holdings, Inc. engages in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded in April 2007 and is headquartered in Solana Beach...Read more
Market Cap
$24.29M
1 Year High
$11.25
Volume
7.6k
1 Year Low
$2.24
Price to Earnings Ratio
Open
$2.71
Dividend Rate
High
$2.79
Dividend Yield
Low
$2.36

Community

People who own or watch ONVO stock

Organovo Hlds Stock News

Organovo Hlds stock rating

What analysts recommend for ONVO stock, on a scale from 1 (buy) to 5 (sell).
Buy
Sell
3

Organovo Hlds price target

What analysts think ONVO will be worth
Low $2.24
High $30
Current $2.36
Target $30

Events

List of events that could affect ONVO stock.
14Feb

Earnings data Q4 2021

14Jun

Earnings data Q1 2022

Organovo Hlds earnings

The value each share was expected to gain vs. the value that each share actually gained
0
-7.65
-15.3
-22.95
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019

Expected EPS
Q4 2019
-$1
Actual EPS
Q4 2019
-$0.52

Buy Organovo Hlds (ONVO) Stock

ONVO
See ONVO stock price and Buy/Sell Organovo Hlds with any amount of money. Discuss news and analyst's price prediction with the investor community. Enter your cell phone number to get started.

Community

People who own or watch ONVO stock
  • luxcash avatar
  • TheMoneyPimp avatar
  • bigwilly2212 avatar
  • Thebestinvestor avatar
  • customcrimescene avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency trading is provided by Apex Crypto LLC (“Apex Crypto”). Apex Crypto is not a registered broker-dealer or FINRA member and is not affiliated with Public Holdings or any of its subsidiaries. Cryptocurrencies are not securities and your cryptocurrency holdings are not FDIC or SIPC insured. Crypto trading involves a substantial risk of loss as there is significant volatility in the price of cryptocurrencies.

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.